INS and Alzheimer disease: It suggests that insulin resistance and impaired glucose metabolism in the brain contribute to the neurodegenerative processes seen in AD, leading some researchers to describe AD as type 3 diabetes. This concept highlights the role of insulin dysregulation in cognitive decline.